Keywords
cardiomyoplasty
heart failure
refractory angina
How to Cite
Abstract
The long-term outcomes of cellular cardiomyoplasty in patients with ischemic cardiac dysfunction were studied. The results of treatment of 45 patients aged 46–70 years, mean age is (56.8±19.7) years, who were hospitalized in the Emergency and Reconstmctive Cardiac Surgery Department of the «V.K. Gusak Institute of Emergency and Reconstmctive Surgery of NAMS of Ukraine» from 2007 to 2013 were analyzed. It was established that the transplantation of autologous mesenchymal bone marrow stem cells using the navigation system is a safe and effective procedure, that helps to increase the survival rates up to 35 (18-61) months compared to 12 (0.72-50.0) months in the group of pharmacological therapy (p value = 0.033). Also the reduction of mortality 36 months after the stem cells injection to 13.3 % compared to 46.7 % in the group of pharmacological treatment in the same terms was observed. To achieve the maximum effect of treatment, it is reasonable to repeat the procedure of autologous mesenchymal bone marrow stem cells transplantation 1 year later after the first procedure. Endomyocardial implantation of autologous mesenchymal bone marrow stem cells improves basic dimensions of life quality: physical functioning, pain intensity, usual activity and social functioning regardless of the initial severity of ischemic dysfunction.
Keywords: stem cells, cardiomyoplasty, heart failure, refractory angina.
References
Voronkov, L.H., Berezin, О.Ye., Zharinova, V.Yu., Zhebel, V.M., Koval, O.A., Rudyk, Yu.S., … & Tseluiko, V.Y. (2019). Biolohichni markery ta yikh zastosuvannia pry sertsevii nedostatnosti. Konsensus Vseukrainskoi asotsiatsii kardiolohiv Ukrainy, Vseukrainskoi asotsiatsii fahivtsiv iz sertsevoi nedostatnosti ta Ukrainskoi asotsiatsii fahivtsiv z nevidkladnoi kardiolohii [Biological markers and their use in heart failure Consensus of the All-Ukrainian Association of Cardiologists of Ukraine, the All- Ukrainian Association of Heart Failure Specialists and the Ukrainian Association of Emergency Cardiology Specialists]. Ukrainskyi kardiolohichnyi zhurnal - Ukrainian Journal of Cardiology, 26(2), 19–30. Retrieved from http://ucardioj.com.ua/index.php/UJC/article/view/168 [in Ukrainian].
Nikonenko, A.S., Molodan, A.V, & Ivashchuk, V.A. (2015). Otsenkadeformatsionnykh svoistvmiokarda u bolnykh ishemicheskoi bolezniu serdtsa s vyrazhennoi dilatatsiei polosti levoho zheludochka, oslozhnennoi serdechnoi nedostatochnostiu [Assessment of deformation properties of the myocardium in patients with ischemic heart disease with severe dilatation of the left ventricular cavity, complicated by heart failure]. Vestnik serdechno-sosudistoi hirurhii – Cardiovascular Surgery Herald, (23), 135–139. Retrieved from http://www.cvs.org.ua/cvs-herald/_publs_/herald_23/23_029.pdf [in Russian],
Gabrielian, A.V, Smorzhevskyi, V.Y., Onischenko, V.F., Lukach, P.M., Beleiovych, V.V., & Domanskyi, T.M. (2009). Koroname shuntuvannia u hvorykh IKhS z hronichnoiu sertsevoiu nedostatnistiu [Coronary artery bypass grafting in patients with coronary heart disease with chronic heart failure]. Shchoriclmyk naukovyh prats Asotsiatsii sertsevo-sudynnykh hirurhiv Ukrainy – Yearbook of scientific works of the Association of Cardiovascular Surgeons of Ukraine, (17), 103–107 [in Ukrainian],
Nanayakkara, S., Patel, H.C., & Kaye, D.M. (2018). Hospitalisation in patients with heart failure with preserved ejection fraction. Clin. Med. Insights: Cardiol., (12), 1179546817751609. DOI: 10.1177/1179546817751609. PMID: 29343997.
Dzholdasbekova, A.U., Fedotovskih, G.V., Askarov, M.B., Komsabakova, B.A., Baigenzhina, A.B., Kairatova, A.K., & Abylkassymova, G.U. (2015). Sistemnoie vvedeniie autolohichnykh mononukleamykh prekultivirovannykh kletok kostnoho mozha pri serdechnoi nedostatochnosti [Systemic administration of autologous mononuclear precultured bone marrow cells in heart failure]. Clinical Medicine of Kazakhstan, 3(37), 14–18. Retrieved from https://is.gd/hzhcV5 [in Russian].
Holukhova, Ye.Z., & Kakuchaia, T.T. (2007). Kletochnaia terapiia v kardiolohii і serdechno-sosudistoi hirurhii: obzor randomizirovannykh issledovanii [Cell therapy in cardiology and cardiovascular surgery: a review of randomized trials]. Realii і perspektivy. Kreativnaia kardiolohii a – Realities and Prospects. Creative Cardiology, (1–2), 55–74. Retrieved from https://cardiology-joumal.com/catalog/web/viewer.php [in Russian],
Gryn, V.K., & Mihailichenko, V.Yu. (2012). Patofiziolohicheskiie aspekty kletochnoi kardiomioplastiki pri eksperimentalnom infarkte miokarda [Pathophisiogist aspect of cells cardiomyoplastics in heart with experimental myocardial infarct]. Tavricheskii mediko-biolohicheskii vestnik – Tavrian Biomedical Herald, 15(3), part 1(59), 81–84. Retrieved from http://dspace.nbuv.gov.ua/bitstream/handle/123456789/44455/20-Gryn.pdf [in Russian].
Gabrielian, А.V., Salutin, R.V., Yakushev, А.V., Onischenko, V.F., Shablij, V.M., Domanskiy, T.M. et al. (2014). Suchasni pidhody tametodyky transplantatsii stovburovykh klityn khvorym z terminalnoiu stadiieiu sertsevoi nedostatnosti [Contemporary approaches and methods of stem cell transplantation in patients with end-stage heart failure]. Kardiohirurhiia ta interventsiina kardiolohiia – Cardiac Surgery and Interventional Cardiology, 1(6), 8–12. Retrieved from http://csic.com.ua/ua/nomery/arkhiv-nomeriv/1-2014/251-suchasni-pidkhody-ta-metodyky-transplantatsii-stovburovykh-klityn-khvorym-z- terminalnoiu-stadiieiu-sertsevoi-nedostatnosti [inUkrainian],
Gabrielian, A. V. (2014). Sovremennyie metody hirurhicheskoho lecheniia refraktemoi serdechnoi nedostatotnosti pri ishemicheskoi bolezni serdtsa [Modem methods of surgical treatment of refractory heart failure in coronary heart disease]. Klinichna hirurgiya – Clinical Surgery, 1(2), 52–55. Retrieved from https://himrgiya.com.ua/index.php/joumal/issue/view/71/l-2-2014 [in Russian].
Nishimura, S., Izumi, C., Himura, Y., Kuroda, M., Amano, M., Harita, T. et al. (2019). Very long-term follow-up data of non-ischemic idiopathic dilated cardiomyopathy after beta-blocker therapy: recurrence of left ventricular dysfunction and predictive value of 123I-metaiodobenzylguanidine scintigraphy. Heart Vessels, 34(2), 259–267. DOI: 10.1007/s00380-018-1245-y. PMID: 30143883.
Kanda, R., & Davis, D. (2017). Cellular mechanisms underlying cardiac engraftment of stem cells. Expert Opinion on Biological Therapy, 17(9), 1127–1143. DOI: 10.1080/14712598.2017.1346080. PMID: 28670973.
Gabrielian, A.V., Smorzhevskyi, V.Y., Domanskyi, T.M., & Onischenko, V.F. (2011). Dzherela stovburovykh klityn dlia likuvannia khvorykh z pomshenoiu funktsiieiu skorochennia miokarda [Sources of stem cells for the treatment of patients with impaired myocardial contraction]. Heart and Blood Vessels, 3(35), 89–92. Retrieved from http://heartandvessels.vitapol.com.ua/svizhij_nomer.php?nid=35 [in Ukrainian].